U.S. Physical Therapy, Inc. (NYSE:USPH) Holdings Raised by US Bancorp DE

US Bancorp DE boosted its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 4.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 9,541 shares of the company’s stock after acquiring an additional 399 shares during the quarter. US Bancorp DE’s holdings in U.S. Physical Therapy were worth $846,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in USPH. BNP Paribas Financial Markets raised its holdings in shares of U.S. Physical Therapy by 283.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock valued at $1,425,000 after purchasing an additional 12,445 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of U.S. Physical Therapy by 57.1% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock valued at $223,000 after purchasing an additional 956 shares in the last quarter. State Street Corp grew its stake in U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after buying an additional 99,244 shares during the last quarter. Stifel Financial Corp grew its stake in U.S. Physical Therapy by 12.1% in the 3rd quarter. Stifel Financial Corp now owns 57,166 shares of the company’s stock valued at $4,838,000 after buying an additional 6,154 shares during the last quarter. Finally, Quest Partners LLC grew its stake in U.S. Physical Therapy by 2,368.2% in the 3rd quarter. Quest Partners LLC now owns 8,614 shares of the company’s stock valued at $729,000 after buying an additional 8,265 shares during the last quarter.

Wall Street Analysts Forecast Growth

USPH has been the topic of a number of research analyst reports. Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. StockNews.com lowered shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research note on Friday, February 28th. William Blair reiterated a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Barrington Research lowered their target price on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. Finally, JMP Securities initiated coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They issued an “outperform” rating and a $113.00 target price on the stock. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $111.50.

Insider Transactions at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the firm’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the transaction, the chief operating officer now directly owns 7,168 shares of the company’s stock, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.70% of the stock is owned by insiders.

U.S. Physical Therapy Stock Performance

NYSE USPH opened at $79.87 on Tuesday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The firm has a market capitalization of $1.21 billion, a price-to-earnings ratio of 84.96, a P/E/G ratio of 3.54 and a beta of 1.51. The company’s fifty day moving average is $87.21 and its two-hundred day moving average is $87.56. U.S. Physical Therapy, Inc. has a 52-week low of $76.18 and a 52-week high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). The company had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. Equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be given a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.25%. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 97.83%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.